CHENGDU EASTON BIOPHARMACEUTICALS CO., LTD.

Highlights Chengdu Easton Biopharmaceuticals Co., Ltd.

Equities

688513

CNE100004397

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 29/05/2024 am IST			5-day change	1st Jan Change
55.3 ^CNY	-1.67%		-3.29%	-13.30%

22/05	China Gives Green Light for Easton Biopharma's Arterial Occlusive Disease Tablets	MT
22/04	Chengdu Easton Biopharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Chengdu Easton Biopharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	22/04	CI
Easton Biopharma's Unit Gets Nod to Market Bisoprolol Amlodipine Tablets	16/04	MT
Chengdu Easton Biopharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	23/02	CI
Tranche Update on Chengdu Easton Biopharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on August 14, 2023.	04/01	CI
Chengdu Easton Biopharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/23/26	CI
Chengdu Easton Biopharma's Antiepileptic Drug Gets Marketing Nod in China	18/23/18	MT
Tranche Update on Chengdu Easton Biopharmaceuticals Co., Ltd.'s Equity Buyback Plan announced on August 14, 2023.	11/23/11	CI
Easton Biopharma Unit's Production Line Passes US FDA Inspection	25/23/25	MT
Chengdu Easton Biopharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	17/23/17	CI
Chengdu Easton Biopharma to Repurchase Up to 200 Million Yuan Shares	15/23/15	MT
Chengdu Easton Biopharmaceuticals Co., Ltd. announces an Equity Buyback for CNY 200 million worth of its shares.	14/23/14	CI
Chengdu Easton Biopharmaceuticals Co., Ltd. authorizes a Buyback Plan.	14/23/14	CI
Chengdu Easton Biopharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/23/27	CI
Chengdu Easton Biopharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/23/27	CI
Chengdu Easton Biopharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	20/22/20	CI
Chengdu Easton Biopharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	27/22/27	CI
Chengdu Easton Biopharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22/22/22	CI
Chengdu Easton Biopharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	25/22/25	CI
Chengdu Easton Biopharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21/21/21	CI
Chengdu Easton Biopharmaceuticals Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	29/21/29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Chengdu Easton Biopharmaceuticals Co., Ltd.

Equities

688513

CNE100004397

Highlights

Filters